High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021

This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021.

Detalles Bibliográficos
Autores principales: Pathak, Kavya, Narang, Claire, Hwang, Thomas J., Espinoza, Juan C., Bourgeois, Florence T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641589/
https://www.ncbi.nlm.nih.gov/pubmed/36342722
http://dx.doi.org/10.1001/jamapediatrics.2022.4131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641589/
https://www.ncbi.nlm.nih.gov/pubmed/36342722
http://dx.doi.org/10.1001/jamapediatrics.2022.4131

Ejemplares similares